Year: 2022
Type: article
Abstract: The cyclic oligonucleotide-based antiphage signalling system (CBASS) and the pyrimidine cyclase system for antiphage resistance (Pycsar) are antiphage defence systems in diverse bacteria that use cyclic nucleotide signals to induce cell death and prevent viral propagation 1,2 . Phages use several strategies to defeat host CRISPR and restriction-modification systems 3–10 , but no mechanisms are known to evade CBASS and Pycsar immunity. Here we show that phages encode anti-CBASS (Acb) and anti-Pycsar (Apyc) proteins that counteract defence by specifically degrading cyclic nucleotide signals that activate host immunity. Using a biochemical screen of 57 phages in Escherichia coli and Bacillus subtilis , we discover Acb1 from phage T4 and Apyc1 from phage SBSphiJ as founding members of distinct families of immune evasion proteins. Crystal structures of Acb1 in complex with 3′3′-cyclic GMP–AMP define a mechanism of metal-independent hydrolysis 3′ of adenosine bases, enabling broad recognition and degradation of cyclic dinucleotide and trinucleotide CBASS signals. Structures of Apyc1 reveal a metal-dependent cyclic NMP phosphodiesterase that uses relaxed specificity to target Pycsar cyclic pyrimidine mononucleotide signals. We show that Acb1 and Apyc1 block downstream effector activation and protect from CBASS and Pycsar defence in vivo. Active Acb1 and Apyc1 enzymes are conserved in phylogenetically diverse phages, demonstrating that cleavage of host cyclic nucleotide signals is a key strategy of immune evasion in phage biology.
Source: Nature
Authors: Samuel J. Hobbs, Tanita Wein, Allen Lu, Benjamin R. Morehouse, Julia Schnabel, Azita Leavitt, Erez Yirmiya, Rotem Sorek, Philip J. Kranzusch
Language: English
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $11,390
Funders: Burroughs Wellcome Fund, Cancer Research Institute, G. Harold and Leila Y. Mathers Charitable Foundation, Massachusetts Institute of Technology, Parker Institute for Cancer Immunotherapy, Mark Foundation For Cancer Research, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Minerva Foundation, Deutsche Forschungsgemeinschaft, Israel Science Foundation, National Institutes of Health, National Institute of General Medical Sciences, National Center for Research Resources, Argonne National Laboratory, H2020 European Research Council
Awards: G1013400657, G107546177, Mechanism of activation of a new cGAS-like enzyme in humans, G1367129105, G1664757510, Charakterisierung von AntiPhagenVerteidigungsinseln in Prokaryoten, G2243496305, G3075337988, Pixel Array Detector for X-ray Crystallography, Pixel Array Detector for Macromolecular Crystallography, G5824513712, G6479334997, Understanding the pan-immune system of bacteria, Discovery of cGAS-like signaling enzymes in innate immunity and disease, NE-CAT: A Resource for Advanced Macromolecular Crystallography
OpenAlex ID: W4223506823
